Clonal hematopoiesis in the phase 3 Alliance A031201 trial of metastatic castration resistant prostate cancer (mCRPC) treated with androgen receptor (AR)-targeted therapies
- Citation:
- J Clin Oncol vol 41 (suppl 16) 5021
- Meeting Instance:
- ASCO 2023
- Year:
- 2023
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 4304
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Astellas
- Grants:
- U10 CA180821, U10 CA180821, U24 CA196171
- Corr. Author:
- Authors:
- Jeffrey L. Jensen Olivia Bobek Irenaeus Chan David Hillman Glenn Heller Todd Druley Michael J. Morris Matthew Milowsky Himisha Beltran Kelly Bolton Catherine C. Coombs
- Networks:
- CA088, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-NY016
- Study
- Alliance-A031201
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: